Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy
Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Feb 14, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Moms@Home trial is a study designed to see how a digital health program can help pregnant women manage their blood pressure at home. This program uses storytelling and mobile technology to support women who have high blood pressure during pregnancy, either from chronic hypertension or gestational hypertension. The goal is to improve how these women monitor their blood pressure and ultimately ensure healthier pregnancies.
To participate in this trial, women must be between the ages of 18 and 50, speak either English or Spanish, and have a diagnosis of high blood pressure during pregnancy. They should be comfortable using smartphones and willing to share their home blood pressure readings. Women with severe high blood pressure, certain medical conditions, or those currently using other monitoring programs may not be eligible. If selected, participants can expect to engage with the Moms@Home program, which aims to provide helpful tools and support for managing their health during pregnancy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18-50
- • English or Spanish speaking
- • A diagnosis of gestational (20-26 weeks gestational age) or chronic hypertension (8-26 weeks gestational age)
- • Singleton or multiple gestation pregnancy,
- • A patient of the University of Massachusetts Memorial Health Obstetrics/Maternal and Fetal Medicine clinics in Worcester, Massachusetts
- • Willing to share home blood pressure monitoring data
- • Comfortable with the use of smartphones and mobile apps
- Exclusion Criteria:
- • Severe hypertension (Systolic blood pressure ≥160 mmHg or Diastolic blood pressure ≥100 mmHg)
- • Current diagnosis of preeclampsia
- • Active substance use
- • Serious physical illness (e.g., unable to interact with a smart device)
- • Enrolled in another home blood pressure monitoring program
- • Excluded from study participation by their provider
- • Inability to provide informed consent
- • Prisoners/institutionalized individuals
About University Of Massachusetts, Worcester
The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Worcester, Massachusetts, United States
Patients applied
Trial Officials
Lara Kovell, MD,MSc
Principal Investigator
University of Massachusetts Medical School, Worcester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported